252 related articles for article (PubMed ID: 17905619)
1. Montelukast inhibits inflammatory responses in small airways of the Guinea-pig.
Harrison S; Gatti R; Baraldo S; Oliani KL; Andre E; Trevisani M; Gazzieri D; Saetta M; Geppetti P
Pulm Pharmacol Ther; 2008; 21(2):317-23. PubMed ID: 17905619
[TBL] [Abstract][Full Text] [Related]
2. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
[TBL] [Abstract][Full Text] [Related]
3. Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model.
Muraki M; Imbe S; Santo H; Sato R; Sano H; Iwanaga T; Tohda Y
Int Arch Allergy Immunol; 2011; 155 Suppl 1():90-5. PubMed ID: 21646802
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs.
Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; Matsumura N; Fujita M; Kawabata K
Eur J Pharmacol; 2015 May; 754():98-104. PubMed ID: 25704617
[TBL] [Abstract][Full Text] [Related]
5. Effects of KP-496, a novel dual antagonist at the cysteinyl leukotriene receptor 1 and the thromboxane A(2) receptor, on airway obstruction in guinea pigs.
Ishimura M; Suda M; Morizumi K; Kataoka S; Maeda T; Kurokawa S; Hiyama Y
Br J Pharmacol; 2008 Feb; 153(4):669-75. PubMed ID: 18037905
[TBL] [Abstract][Full Text] [Related]
6. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous effect of leucotriene CysLT1 receptor antagonists on antigen-induced motor and inflammatory responses in guinea-pig airways.
Alfieri AB; Tramontana M; Cialdai C; Lecci A; Giuliani S; Crea A; Manzini S; Maggi CA
Auton Autacoid Pharmacol; 2007 Jan; 27(1):39-46. PubMed ID: 17199874
[TBL] [Abstract][Full Text] [Related]
8. Montelukast modulates lung CysLT(1) receptor expression and eosinophilic inflammation in asthmatic mice.
Zhang YJ; Zhang L; Wang SB; Shen HH; Wei EQ
Acta Pharmacol Sin; 2004 Oct; 25(10):1341-6. PubMed ID: 15456537
[TBL] [Abstract][Full Text] [Related]
9. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
10. Montelukast prevents the decrease of interleukin-10 and inhibits NF-kappaB activation in inflammatory airway of asthmatic guinea pigs.
Wu Y; Zhou C; Tao J; Li S
Can J Physiol Pharmacol; 2006 May; 84(5):531-7. PubMed ID: 16902598
[TBL] [Abstract][Full Text] [Related]
11. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW
Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
[TBL] [Abstract][Full Text] [Related]
12. Effects of ONO-6950, a novel dual cysteinyl leukotriene 1 and 2 receptors antagonist, in a guinea pig model of asthma.
Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; inoue A; Nakao T; Nomura H; Murata M; Nakao S; Nambu F; Fujita M; Nakade S; Kawabata K
Eur J Pharmacol; 2015 Oct; 765():242-8. PubMed ID: 26318198
[TBL] [Abstract][Full Text] [Related]
13. Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin-sensitized guinea-pigs in vitro.
Liu YC; Khawaja AM; Rogers DF
Br J Pharmacol; 1998 Jun; 124(3):563-71. PubMed ID: 9647482
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of leukotriene receptor antagonists.
Aharony D
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S214-8; discussion S218-9, S247-8. PubMed ID: 9647602
[TBL] [Abstract][Full Text] [Related]
15. Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma.
De Lepeleire I; Reiss TF; Rochette F; Botto A; Zhang J; Kundu S; Decramer M
Clin Pharmacol Ther; 1997 Jan; 61(1):83-92. PubMed ID: 9024176
[TBL] [Abstract][Full Text] [Related]
16. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
Ikeda G; Miyahara N; Koga H; Fuchimoto Y; Waseda K; Kurimoto E; Taniguchi A; Tanimoto Y; Kataoka M; Tanimoto M; Kanehiro A
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):18-29. PubMed ID: 23937413
[TBL] [Abstract][Full Text] [Related]
17. Antileukotriene treatment and allergic rhinitis-related cough in guinea pigs.
Brozmanova M; Plevkova J; Bartos V; Plank L; Tatar M
J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():21-30. PubMed ID: 16204773
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist.
Jones TR; Labelle M; Belley M; Champion E; Charette L; Evans J; Ford-Hutchinson AW; Gauthier JY; Lord A; Masson P
Can J Physiol Pharmacol; 1995 Feb; 73(2):191-201. PubMed ID: 7621356
[TBL] [Abstract][Full Text] [Related]
19. Effects of cysteinyl leukotrienes in small human bronchus and antagonist activity of montelukast and its metabolites.
Mechiche H; Naline E; Candenas L; Pinto FM; Birembault P; Advenier C; Devillier P
Clin Exp Allergy; 2003 Jul; 33(7):887-94. PubMed ID: 12859443
[TBL] [Abstract][Full Text] [Related]
20. Mast cell mediators cause early allergic bronchoconstriction in guinea-pigs in vivo: a model of relevance to asthma.
Riley JP; Fuchs B; Sjöberg L; Nilsson GP; Karlsson L; Dahlén SE; Rao NL; Adner M
Clin Sci (Lond); 2013 Dec; 125(11):533-42. PubMed ID: 23799245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
